Álvaro Díaz-González Selected Research

Álvaro Díaz-González Research Topics

11	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 12/2017
6	Neoplasms (Cancer) 01/2024 - 01/2016
5	Fibrosis (Cirrhosis) 03/2024 - 10/2019
3	Hepatitis 01/2024 - 01/2023
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 03/2024 - 11/2022
2	Colitis 01/2024 - 01/2024
2	Autoimmune Hepatitis 01/2023 - 08/2022
1	Splenomegaly 03/2024
1	Portal Hypertension 03/2024
1	Liver Diseases (Liver Disease) 03/2024
1	Varicose Veins (Varicose Vein) 03/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Cholangiocarcinoma 11/2021
1	Body Weight (Weight, Body) 01/2021
1	Exocrine Pancreatic Insufficiency 01/2021
1	Crohn Disease (Crohn's Disease) 01/2018
1	Pathologic Constriction (Stenosis) 01/2018

7	Sorafenib (BAY 43-9006)FDA Link 12/2021 - 01/2018
4	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2021
2	obeticholic acidIBA 03/2024 - 11/2022
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2023 - 08/2022
2	Prednisone (Sone)FDA LinkGeneric 01/2023 - 08/2022
2	regorafenibIBA 12/2021 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	lenvatinibIBA 10/2020 - 01/2019
1	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024
1	AlbuminsIBA 03/2024
1	Fibric Acids (Fibrates)IBA 03/2024
1	BilirubinIBA 12/2023
1	Antinuclear AntibodiesIBA 01/2023
1	AntigensIBA 01/2023
1	GlucocorticoidsIBA 08/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2021
1	atezolizumabIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	EnzymesIBA 01/2021
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2020
1	InterferonsIBA 10/2019
1	Antiviral Agents (Antivirals)IBA 10/2019
1	Capsules (Microcapsules)IBA 01/2018